Livelsberger Financial Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $847K | Buy |
4,564
+435
| +11% | +$80.7K | 16.4% | 1 |
|
|
2025
Q1 | $865K | Buy |
4,129
+17
| +0.4% | +$3.56K | 41.31% | 1 |
|
|
2024
Q4 | $731K | Buy |
4,112
+19
| +0.5% | +$3.38K | 34.21% | 1 |
|
|
2024
Q3 | $808K | Buy |
4,093
+17
| +0.4% | +$3.36K | 16.94% | 1 |
|
|
2024
Q2 | $699K | Buy |
4,076
+20
| +0.5% | +$3.43K | 10.43% | 2 |
|
|
2024
Q1 | $655K | Buy |
4,056
+17
| +0.4% | +$2.75K | 7.76% | 3 |
|
|
2023
Q4 | $626K | Buy |
+4,039
| New | +$626K | 0.56% | 43 |
|